Metastatic Prostate Cancer on the Rise as Screenings Decreased
The incidence rate of metastatic prostate cancer increased for men 45 and older and coincides with recommendations against screenings.
Read MorePosted by Andy Lundin | Mar 14, 2022 | Prostate |
The incidence rate of metastatic prostate cancer increased for men 45 and older and coincides with recommendations against screenings.
Read MorePosted by Andy Lundin | Mar 7, 2022 | Prostate |
Researchers have developed a semiconductor sensor capable of detecting ultra-low concentrations of tumor markers, on chips made using micromachine tech.
Read MorePosted by Andy Lundin | Mar 2, 2022 | Cancer |
Promising applications of AI include identifying early-stage cancers, inferring the site of the specific cancer, predicting response to immunotherapy, etc.
Read MorePosted by Andy Lundin | Feb 15, 2022 | Prostate |
The FDA has granted Breakthrough Device Designation for Datar Cancer Genetics’ TriNetra-Prostate blood test to detect early-stage prostate cancer.
Read MorePosted by Andy Lundin | Jan 31, 2022 | Cancer, Point-of-Care |
The detection and quantification of cancer-associated molecular biomarkers in body fluids prove minimally invasive in early cancer diagnostics.
Read More